HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Clovis Oncology, Inc. (CLVS)
5.58  -0.045  (-0.8%) 10-26 02:26
Open: 5.67 High: 5.72
Pre.close: 5.625 Low: 5.36
Volume: 4,090,186 Ave vol: 4,793,500
52w High: 17.37 52w Low: 2.93
MA(50): 6.077 MA(200): 6.667
EPS: -5.887 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Website: http://clovisoncology.com
Market Cap (M): 492
Shares Out (M): 88
Clovis Oncology, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of cancer treatments. The company is headquartered in Boulder, Colorado and currently employs 468 full-time employees. The Company’s product Rubraca (rucaparib), an oral small molecule inhibitor of poly adenosine diphosphate (ADP)-ribose polymerase (PARP), is marketed in the United States for two indications specific to recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. The firm also provides Lucitanib, which is an investigational, oral, potent inhibitor of the tyrosine kinase activity of vascular endothelial growth factor receptors one through three (VEGFR1-3), platelet-derived growth factor receptors alpha and beta, and fibroblast growth factor receptors one through three (FGFR1-3).
Technical analysis
Overall: Underperform
MA: Bearish MACD: Bearish
KDJ: Bearish RSI: Bearish
Target 1: 7.64 Target 2: 8.49
Resist 1: 6.54 Resist 2: 7.27
Support 1: 5.36 Support 2: 4.46
Company key metrics
Revenue per Share: 2.6545
Net Income per Share: -7.4327
Cash per Share: 3.004
Book Value per Share: -3.2346
Price to Sales: 3.2473
Price to Book Value: -2.6649
Earnings Yield: -0.8623
Dividend Yield: 0
Debt to Equity: -4.8426
Debt to Assets: 1.2602
Financial analysis
Price to Book Value: Underperform
Return on Assets: Underperform
Return on Equity: Outperform
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Underperform
Stock Charts

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.